Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
perindopril arginine, Quantity: 2.5 mg
Arrotex Pharmaceuticals Pty Ltd
perindopril arginine
Tablet, film coated
Excipient Ingredients: macrogol 8000; titanium dioxide; magnesium stearate; hyprolose; colloidal anhydrous silica; isomalt; hypromellose
Oral
100, 10, 30
(S4) Prescription Only Medicine
Treatment of hypertension and the treatment of heart failure. In such patients it is recommended that perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and patients with established coronary artery disease (See Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
Visual Identification: White coloured, round shaped, biconvex, film coated tablets, with engraved APO on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2012-04-26